PAM-DB: Revealing Protein Activation Mechanisms for Next-Generation Rational Drug Discovery

PAM-DB: Unveiling Protein Activation Mechanisms for Next-Generation Drug Discovery

Traditional rational drug design primarily utilizes computational methods to model binding thermodynamics and static shapes of target proteins, mainly in their inactive states. However, the crucial kinetic parameters that influence experimental efficacy - such as catalytic turnover and signaling potency - are determined by molecular interactions with transition states, intermediate states, and the entire range of conformations along the least free-energy activation pathway.

This lack of dynamic information has significantly constrained the predictive power and success rate of conventional structure-based approaches.

The PAM-DB database systematically maps the complete activation trajectories of pharmacologically relevant targets, including transition states, intermediate states, and all connecting conformational ensembles. This resource provides several advantages for drug discovery: it allows for rational targeting of previously undruggable proteins, facilitates biased agonism/antagonism design, reveals cryptic allosteric sites in inactive conformations, identifies novel transient pockets along the activation route, rationalizes the mechanisms of existing drugs, predicts mutational effects on activation barriers, and prospectively forecasts drug resistance and off-target liabilities.

The utility of PAM-DB is demonstrated through case studies, and guidelines for integration into existing discovery pipelines are provided. For more detailed information, visit the database website at https://www.momedpamdb.com/en.